Nektar Therapeutics | NKTR - Cash And Equivalent


Nektar Therapeutics reported $41.03M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Agios Pharmaceuticals USD 89.13M 3.58M Dec/2025
ALKERMES USD 388.57M 227.88M Dec/2025
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Amgen USD 9.13B 316M Dec/2025
Baxter International USD 1.97B 240M Dec/2025
BioCryst Pharmaceuticals USD 84.08M 3.95M Sep/2025
Biogen USD 3.01B 854.3M Dec/2025
Bristol-Myers Squibb USD 10.21B 5.52B Dec/2025
Cara Therapeutics USD 20.65M 13.57M Jun/2025
Cipla INR 7.96B 39.9M Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Eisai JPY 301.65B 16.27B Sep/2025
Eli Lilly USD 7.27B 2.52B Dec/2025
Esperion Therapeutics USD 92.45M 6.39M Sep/2025
Exelixis USD 482.49M 106.19M Dec/2025
Gilead Sciences USD 7.33B 2.19B Sep/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
Grifols EUR 979.78M 334.84M Dec/2024
Halozyme Therapeutics USD 133.82M 285.84M Dec/2025
Incyte USD 3.58B 650.78M Dec/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
Ironwood Pharmaceuticals USD 140.41M 47.56M Sep/2025
Karyopharm Therapeutics USD 37.67M 1.05M Sep/2025
MacroGenics USD 80.13M 50.56M Sep/2025
Merck USD 18.17B 10.16B Sep/2025
Nektar Therapeutics USD 41.03M 1.96M Sep/2025
Neurocrine Biosciences USD 713M 372.8M Dec/2025
Novartis USD 9.56B 2.9B Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sarepta Therapeutics USD 801.28M 188.2M Dec/2025
Takeda JPY 654.94B 26.55B Dec/2025
Teva Pharmaceutical Industries USD 3.56B 1.35B Dec/2025
Xencor USD 54.07M 25.78M Dec/2025